Guizhou Xinbang Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 6,655.063 million compared to CNY 6,580.278 million a year ago. Operating income was CNY 345.004 million compared to operating loss of CNY 1,195.362 million a year ago. Net income was CNY 236.301 million compared to net loss of CNY 1,296.605 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to basic loss per share from continuing operations of CNY 0.8 a year ago.